RD Center - Products and Research - Wuhan YZY Biopharma Co., Ltd.

Home
About YZYBIO

Company Overview Leadership Team Milestones Contact Us
Science and Technology

Research Area Technology Platforms Product Pipeline Production Operation Partnerships Publication
Products and Research

RD Center Scientific Progress
Investor Relations

Corporate Governance Information Disclosure IR Calendar Presentation and Webcast Press Release Paperless Corporate Communications
News

Press Release Media Report
Careers

Corporate Culture Careers Development

: 中文

Home
About YZYBIO
About YZYBIO Company Overview Leadership Team Milestones Contact Us
Science and Technology
Science and Technology Research Area Technology Platforms Product Pipeline Production Operation Partnerships Publication
Products and Research
Products and Research RD Center Scientific Progress
Investor Relations
Investor Relations Corporate Governance Information Disclosure IR Calendar Presentation and Webcast Press Release Paperless Corporate Communications
News
News Press Release Media Report
Careers
Careers Corporate Culture Careers Development
简体 English

Products and Research

Develop innovative drugs to safeguard human health

RD Center
Scientific Progress

CD3 EpCAM VEGF TGF-β ANG-2

Home > Products and Research

RD Center

With the mission of "Develop innovative drugs to safeguard human health", YZYBIO has established a visionary and seasoned R&D team and an integrated research and development platform, continuing to develop innovative technologies and product pipelines to develop BsAb-based therapies treatments for cancer or cancer-associated complications, cancer and age-related ophthalmologic diseases. The Company has designed and developed a pipeline of 7 clinical-stage drug candidates.